Roivant Sciences is a biopharmaceutical holding company that develops and commercializes medicines and health technologies through a network of subsidiary 'vant' companies.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 76 | Added +361% | 4,495,778 | $159,105,583 | 0.2% |
| Paul Tudor Jones / Tudor | 63 | Added +437% | 95,100 | $3,365,589 | 0.0% |
| David Einhorn / Greenlight | 44 | Holds (flat) | 2,152,669 | $76,182,956 | 1.9% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.